Stay updated on Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a routine site update to the framework that does not alter study content or functionality.
    Difference
    0.1%
    Check dated 2026-05-15T15:42:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page footer revision number was updated from v3.5.2 to v3.5.3, reflecting a site software/version change rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:29:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:51:47.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The site software revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:15:03.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    - The revision label updated from v3.4.2 to v3.4.3. The page content otherwise remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-12T02:29:17.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The site updated to revision v3.4.2, and the previous notice about government funding and operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:08:32.000Z thumbnail image

Stay in the know with updates to Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brigatinib Post Next-Gen ALK Inhibitors Clinical Trial page.